Loading ...

LaSonia Morgan

Rho

Senior Clinical Data Project Manager

Assessment Group

LaSonia_Morgan@rhoworld.com

Work:

919-595-6379

Mobile:

Address:

Rho

Committees:

,

Studies:

ITN021AI

-

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

ITN025AD

-

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children

ITN027AI

-

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN034AI

-

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

ITN035AI

-

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

ITN045AI

-

Inducing Remission in Type 1 Diabetes With Alefacept

ITN047AI

-

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin

ITN055AI

-

Rituximab and Belimumab for Lupus Nephritis

ITN059AI

-

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris

ITN066AI

-

Type 1 Diabetes Extension Study

ITN070AD

-

ITN075AI

-

Brentuximab Vedotin for Systemic Sclerosis

ITN084AD

-

Grass Pollen Immunotherapy plus Dupilumab for Tolerance Induction

ITN086AI

-

Evaluation of AMG 714 for Vitiligo

Bio:

Admin Links

Shortcuts

ITN Documents

Links